Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.4592 | 0.6234 | 1 |
Echinococcus granulosus | sodium:glucose cotransporter 2 | 0.4489 | 0.6048 | 0.6048 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.1309 | 0.0297 | 0.0343 |
Loa Loa (eye worm) | hypothetical protein | 0.2618 | 0.2665 | 0.308 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.4592 | 0.6234 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.3846 | 0.4885 | 0.7608 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.1475 | 0.0597 | 0.5 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.3448 | 0.4166 | 0.6332 |
Schistosoma mansoni | inositol transporter | 0.4489 | 0.6048 | 0.6048 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.4426 | 0.5934 | 0.9468 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.1475 | 0.0597 | 0.0957 |
Echinococcus granulosus | sodium:glucose cotransporter | 0.4489 | 0.6048 | 0.6048 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.4592 | 0.6234 | 1 |
Onchocerca volvulus | 0.1145 | 0 | 0.5 | |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.4592 | 0.6234 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.1873 | 0.1316 | 0.1276 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.2618 | 0.2665 | 0.4274 |
Giardia lamblia | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.2703 | 0.2817 | 0.5 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.3448 | 0.4166 | 0.6332 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.5928 | 0.8651 | 1 |
Echinococcus multilocularis | sodium:myo inositol cotransporter | 0.4489 | 0.6048 | 0.6048 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.6674 | 1 | 1 |
Echinococcus granulosus | solute carrier family 5 | 0.4489 | 0.6048 | 0.6048 |
Schistosoma mansoni | inositol transporter | 0.4489 | 0.6048 | 0.6048 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.1475 | 0.0597 | 0.0597 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase vps34-like | 0.1475 | 0.0597 | 0.0505 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.2618 | 0.2665 | 0.2665 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.4592 | 0.6234 | 1 |
Echinococcus multilocularis | solute carrier family 5 | 0.4489 | 0.6048 | 0.6048 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.2618 | 0.2665 | 0.2665 |
Loa Loa (eye worm) | hypothetical protein | 0.1973 | 0.1498 | 0.1731 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.4592 | 0.6234 | 1 |
Echinococcus multilocularis | sodium:glucose cotransporter 2 | 0.4489 | 0.6048 | 0.6048 |
Echinococcus granulosus | sodium:myo inositol cotransporter | 0.4489 | 0.6048 | 0.6048 |
Toxoplasma gondii | transporter, solute:sodium symporter (SSS) family protein | 0.1145 | 0 | 0.5 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.2082 | 0.1694 | 0.2718 |
Entamoeba histolytica | hypothetical protein | 0.3846 | 0.4885 | 0.7608 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.6674 | 1 | 1 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.4592 | 0.6234 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 16 nM | Antimalarial activity against the chloroquine sensitive NF54 strain of Plasmodium falciparum | ChEMBL. | 9925735 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.